INMUNE BIO INC. Depreciation
INMUNE BIO INC. (INMB) reported Depreciation of $100.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- INMUNE BIO INC. depreciation for the quarter ending 2026-06-30 was $100.00K.
- INMUNE BIO INC. depreciation for the quarter ending 2026-03-31 was $52.00K.
- INMUNE BIO INC. depreciation for the quarter ending 2025-12-31 was $56.00K.
- INMUNE BIO INC. depreciation for fiscal 2025 was $84.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $100.00K 10-Q · filed 2026-08-06 | $118.00K 10-Q · filed 2026-08-06 | $208.00K derived: sum of 3 quarters · filed 2026-08-06 | |
| 2026-03-31 | $52.00K 10-Q · filed 2026-05-07 | $108.00K derived: sum of 2 quarters · filed 2026-05-07 | ||
| 2025-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $84.00K 10-K · filed 2026-03-30 | ||
| 2025-09-30 | $28.00K 10-Q · filed 2025-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |